Literature DB >> 7535866

Characterization and modification of the carboxy-terminal sequences of bluetongue virus type 10 NS1 protein in relation to tubule formation and location of an antigenic epitope in the vicinity of the carboxy terminus of the protein.

K Monastyrskaya1, E A Gould, P Roy.   

Abstract

Bluetongue virus produces large numbers of tubules during infection. The tubules are formed from a 552-amino-acid, 64-kDa NS1 protein encoded by the viral double-stranded RNA segment M6. A series of deletion and extension mutants of bluetongue virus serotype 10 NS1 has been generated and expressed in insect cells in order to identify the carboxy-terminal components of the protein which are important for tubule formation. The mutants AcCT5 and AcCT10, lacking 5 and 10 of the carboxy-terminal residues, respectively, were prepared. By analyzing their abilities to form tubules, it was shown that AcCT5 was capable of this function whereas AcCT10 was not, indicating that the last five amino acids are not strongly involved in NS1 tubule formation. Extension mutants including foreign antigenic sequences involving up to 16 amino acids added to the C terminus of NS1 were shown to form tubules, although an extension of 19 amino acids inhibited tubule formation. Analysis of a panel of monoclonal antibodies has established that an NS1 antigenic site is located near the carboxy terminus of the protein. It appears to be exposed on the surface of tubules. The opportunities to develop new vaccines using recombinant NS1 to deliver foreign epitopes are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535866      PMCID: PMC188978     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Protein synthesis in bluetongue virus-infected cells.

Authors:  H Huismans
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus.

Authors:  N Cammack; E A Gould
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

Review 3.  Structure of the bluetongue virus genome and its encoded proteins.

Authors:  P Roy; J J Marshall; T J French
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10.

Authors:  J Lee; P Roy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

5.  Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies.

Authors:  F A Murphy; E C Borden; R E Shope; A Harrison
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

6.  Use of the biotin-streptavidin interaction to improve flavivirus detection by immunofluorescence and ELISA tests.

Authors:  E A Gould; A Buckley; N Cammack
Journal:  J Virol Methods       Date:  1985-05       Impact factor: 2.014

7.  Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

8.  A comparison of different cloned bluetongue virus genome segments as probes for the detection of virus-specified RNA.

Authors:  H Huismans; M Cloete
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Expression of the non-structural protein NS1 of bluetongue virus in bacteria and yeast: identification of two antigenic sites at the amino terminus.

Authors:  A R Gould; J C Martyn; L Stevenson
Journal:  Virus Res       Date:  1994-03       Impact factor: 3.303

View more
  9 in total

1.  Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.

Authors:  Natasha Larke; Aileen Murphy; Christoph Wirblich; Denise Teoh; Marie J Estcourt; Andrew J McMichael; Polly Roy; Tomás Hanke
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.

Authors:  Randall J Owens; Chang Limn; Polly Roy
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Atomic structure of the translation regulatory protein NS1 of bluetongue virus.

Authors:  Adeline Kerviel; Peng Ge; Mason Lai; Jonathan Jih; Mark Boyce; Xing Zhang; Z Hong Zhou; Polly Roy
Journal:  Nat Microbiol       Date:  2019-02-18       Impact factor: 17.745

4.  Multiple genome segments determine virulence of bluetongue virus serotype 8.

Authors:  Anna Janowicz; Marco Caporale; Andrew Shaw; Salvatore Gulletta; Luigina Di Gialleonardo; Maxime Ratinier; Massimo Palmarini
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

5.  CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR-/- Mice.

Authors:  Alejandro Marín-López; Eva Calvo-Pinilla; Diego Barriales; Gema Lorenzo; Alejandro Brun; Juan Anguita; Javier Ortego
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 6.  Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Authors:  Luis Jiménez-Cabello; Sergio Utrilla-Trigo; Natalia Barreiro-Piñeiro; Tomás Pose-Boirazian; José Martínez-Costas; Alejandro Marín-López; Javier Ortego
Journal:  Vaccines (Basel)       Date:  2022-07-14

7.  Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment.

Authors:  Andrew E Shaw; Maxime Ratinier; Sandro Filipe Nunes; Kyriaki Nomikou; Marco Caporale; Matthew Golder; Kathryn Allan; Claude Hamers; Pascal Hudelet; Stéphan Zientara; Emmanuel Breard; Peter Mertens; Massimo Palmarini
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Characterization of a second open reading frame in genome segment 10 of bluetongue virus.

Authors:  Meredith Stewart; Alexandra Hardy; Gerald Barry; Rute Maria Pinto; Marco Caporale; Eleonora Melzi; Joseph Hughes; Aislynn Taggart; Anna Janowicz; Mariana Varela; Maxime Ratinier; Massimo Palmarini
Journal:  J Gen Virol       Date:  2015-08-19       Impact factor: 3.891

9.  Bluetongue Virus NS4 Protein Is an Interferon Antagonist and a Determinant of Virus Virulence.

Authors:  Maxime Ratinier; Andrew E Shaw; Gerald Barry; Quan Gu; Luigina Di Gialleonardo; Anna Janowicz; Mariana Varela; Richard E Randall; Marco Caporale; Massimo Palmarini
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.